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ABSTRACT
Formation of mammalian lip and palate involves multiple developmental 
steps that finally lead to the fusion of the two bilateral palatal shelves along 
the facial midline. Recent studies confirm that on the basis successful oro-
facial formation is coordinated interactions of several factors including genes, 
growth factors, enzymes and their natural inhibitors. The aim of our study 
was to investigate cleft disordered tissue in children with cleft lip and palate 
for detection of local expression of key regulators of palatogenesis.
The study involved 10 patients with unilateral cleft lip and palate at the 
age of three months to four years and eight months. Tissue samples were 
collected during the surgical procedure from the borders of the cleft region. 
Material was proceed for detection of PAX9, RYK, TGFβ-3, MMP-8, MMP-9 
and TIMP-2 with biotin-streptavidin immunohistochemistry. Distribution of 
immunoreactive structures was detected semiquantitatively.
Expression of PAX9 and RYK was more pronounced in cleft lip and palate 
disordered epithelium. The relative number of PAX9 positive epitheliocytes 
was very variable, while RYK mainly stained few cells localized into middle 
layers. Expression of TGFβ-3 was detected in the tissue of all patients. We saw 
numerous positive epitheliocytes in eight cases, but underlying connective 
tissue mainly demonstrated few or moderate number immunoreactive cells. 
Expression of MMP-8 was found only in epithelium of eight patients and it 
was slight, while MMP-9 and TIMP-2 marked variable number of positive 
epithelial and connective tissue cells.
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Conclusions. Expression of Pax-9 is more characteristic for cleft lip and 
palate affected tissue and probably facilitates tissue reconstruction due to its 
mitogenic effect. Rich expression of TGFβ-3 in cleft lip and palate disordered 
tissue may play a role in successful tissue remodelling and scar-free healing. 
Cleft lip and palate disordered tissue are characterizied by more pronounced 
expression of MMP-9, it slightly predominate expression of TIMP-2, giving 
evidence to the involvement of mentioned factors in the postnatal tissue 
remodeling.
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INTRODUCTION
Clefts of the lip and palate are among the most common birth defects in 
humans and occur at the approximate rate of 1 in 700 live births with wide 
variability related to geographic origin and socioeconomic status [15, 21]. Cleft 
palate is caused by the failed closure of bilateral palatal shelves in the midline 
[21]. 
The development of human secondary palate involves a complex sequence 
of critical events, including the growth, elevation, medial elongation and mid-
line fusion of palatal shelves [5, 21]. Consequently, the bilateral shelves estab-
lish contact at midline at the tip epithelium named the medial edge epithelium 
(MEE), forming the medial epithelial seam (MES) [11]. Complete fusion of the 
secondary palate requires disappearance of the MEE, as well as the breakdown 
of their basement membrane [1]. Exactly, the cell fate of MEE is controversial 
more then 20 years, and among possible mechanisms for the disappearance 
are apoptosis, epithelial/mesenchymal transformation and /or cell migration 
[11]. Studies show, that all mentioned processes are caused and regulated by 
different genes, matrix metalloproteinases (MMPs) and tissue inhibitors of 
metalloproteinases (TIMPs).
The PAX gene family consists of 9 members, that based on the presence or 
absence of structural motifs, are divided into 4 subgroups. The functions and 
role of PAX genes in embryonic development have been elucidated by analy-
sis of naturally occuring mouse mutants and human syndroms. A common 
feature of all PAX mutants is reduction in size and malformation or loss of 
specific organs. Several PAX genes, among them PAX9, are expressed in the 
developing facial processes [4]. 
PAX9 is a key regulator in mesenchyme during the development of a wide 
range of organ primordia, including the palatal shelf. Researchers confirm that 
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there is a direct correlation between Pax-9 expression and palatal fusion [8]. 
Moreover, Heiko and his coworkers showed, that PAX9 regulates the normal 
shape of the palatal shelves prior to shelf elevation. They demonstrated that 
the shelves of PAX9 mutant embryos revealed an abnormally broadened shape 
and lacked characteristic indentations at their ventrolateral sides [9]. 
RYK is an atypical orphan receptor tyrosine kinase that lacks detectable 
kinase activity. The exact function of RYK is unknown, and its ligand has not 
been identified. A mouse model, where RYK was homozygously deleted by 
homologous recombination, revealed an unusual, completely penetrant phe-
notype. The mice were small, compared with wild type, and died within a 
week because of cleft palate [24]. Studies on humans also approve that muta-
tions of RYK is genetic factor for cleft lip and palate [25].
Transforming growth factor beta – 3 (TGFβ-3) orchestrates fusion of the 
palatal seam [14]. It is expressed abundantly by the palatal MEE and is critical 
for the adhesion and disappearance of the MEE during normal palatal shelf 
fusion [23]. In the TGF-β3 null-mutant mice the palatal shelves fail to adhere 
properly, the basement membrane is not degraded and the MEE do no disap-
pear from the midline seem [17]. 
Matrix metalloproteinases (MMPs) are a family of zincdependent proteases 
responsible for tissue remodeling due to their role in extracellular matrix 
remodeling, degrading molecules from the extracellular matrix and basement 
membranes, and in promoting cell migration and proliferation. Together with 
their tissue inhibitors (TIMPs), MMPs have key roles not only during embryo-
genesis but also in homeostasis of adult tissues [12, 16]. Moreover, TGFβ-3 
induces expression of MMPs and following proteolytic degradation of extra-
cellular matrix (ECM) is a necessary step for palatal fusion [1]. 
MATERIAL AND METHODS
The research is based on the material of cleft lip and palate patients, which 
was gathered within a period of time from 2003 to 2006 at the Cleft Lip and 
Palate Centre of the Institute of Stomatology of the Riga Stradins University. 
Permission of the Ethics Committee: decision of the RSU Ethics Committee 
dated 22nd May 2003.
The research involved 10 patients with unilateral cleft lip and palate at the 
age from three months to four years and eight months. Tissue samples were 
collected during the surgical procedure from the borders of the cleft region.
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Tissue were fixed for a day in mixture of 2% formaldehide and 0,2% picric 
acid in 0,1 M phosfate buffer (ph 7,2). After samples were rinsed in thyroide 
buffer, containing 10% sacharose for 12 hours, then embedded into paraffin 
and cut in 6–7 μm thin sections. Sections were proceeded for detection of 
PAX9 gene (PAX9, orb120466, work dilution 1:50, Biorbyt Limited, UK), RYK 
gene (RYK, orb38371, work dilution 1:100, Biorbyt Limited, UK), transforming 
growth factor beta 3 (TGFβ-3, sc-82, work dilution 1:100, Santa Cruz Biotech-
nology, Inc., USA), matrix metalloproteinase 8 (MMP-8, sc-80206, work dilu-
tion: 1:50, Santa Cruz Biotechnology, Inc., USA), matrix metalloproteinase 9 
(MMP-9, sc-10737, work dilution: 1:250, Santa Cruz Biotechnology, Inc., USA), 
tissue inhibitor of matrix metalloproteinases 2 (TIMP-2, sc-21735, work dilu-
tion 1:50, Santa Cruz Biotechnology, Inc., USA) by use of Hsu et al. (1981) bio-
tin – streptavidin immunohistochemical method. Routine histological stain-
ing with haemotoxylin and eosin was developed for each case to get review 
picture of the slide. Distribution of immunoreactive structures were detected 
semiquantitatively [22]. The quantity of structures was analyzed in five visual 
fields of one section. Scale was as following: “0” – no positive structures found 
in visual field, “0/+” – occasional positive structures seen in visual field, “+” – 
few immunoreactive structures seen in visual field, “++” – moderate number 
of immunoreactive structures seen in visual field, “+++” – numerous immu-
noreactive structures seen in visual field, and “++++” – abundance of immu-
noreactive structures seen in visual field.
Results were illustrated using Leica DC 300F camera and the image pro-
cessing and analysis software Image-Pro Plus Version 6.0.
RESULTS
Expression of PAX9 was observed in the tissue of all patients and it was more 
prominent exactly in the epithelium. The relative number of positive epithe-
liocytes was very variable (Table 1). We saw few immunoreactive cells in two 
cases, but moderate number – in five cases. Mentioned cells mainly local-
ized in the middle layers of stratified squamous epithelium and frequently 
were vacuolized. Numerous positive cells we found in three cases, but only in 
one tissue sample they were localized into all layers of epithelium (Figure 1). 
Expression of PAX9 in cleft lip and palate affected connective tissue was less 
pronounced. Mainly we saw few positive cells of connective tissue and/or cells 
of the walls of blood vessels. We didn’t find any positive structure in one case, 
and observed richly stained cells of sebaceous gland in the tissue of one child.
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Table 1. Semiquantitative distribution of immunoreactive structures in the patients with 
unilateral cleft lip and palate
Factors PAX9 RYK TGFβ-3 MMP-8 MMP-9 TIMP-2
Common
evaluation
+–++–+++ 0–0/+–+-++ +–++–+++ 0–++
variable
0–++/+++
variable
0–++/+++
variable
0 – no positive structure seen in the visual field; 0/+ rare positive structures seen in the visual field; + few 
positive structures seen in the visual field; +/++ few to moderate number of positive structures seen in 
the visual field; ++ moderate number of positive structures seen in the visual field; ++/+++ moderate to 
numerous positive structures seen in the visual field; +++ numerous positive structures seen in the visual 
field
__ – the most frequently observed quantity of positive structures
variable – very variable number of positive structures
RYK-containing epithelial cells were seen in the tissue of eight patients and 
their relative number was in the range from occasional to moderate. Mainly 
we found few positive epitheliocytes localized into middle layers. Expression 
of RYK in cleft lip and palate disordered connective tissue again was less pro-
nounced. Mainly we found occasional positive fibroblasts and macrophages 
as well as vascular endothelial and smooth muscle cells. One tissue sample 
showed richly stained cells in the walls of blood vessels (Figure 2) and moder-
ate number positive cells of sebaceous gland. We didn’t observe any positive 
structures of connective tissue into three cases.
 Figure 1. Numerous PAX9 positive 
epithelial cells. Pax9 IMH, X 250.
Figure 2. Numerous RYK immunoreactive 
cells in the walls of blood vesels and 
regionally localized positive epithelial cells. 
Ryk IMH, X 250.
Expression of TGFβ-3 was detected in the tissue of all patients. The relative 
number of positive epitheliocytes was numerous (+++) in eight cases. Interest-
ingly, that positive basal cells we observed in the epithelium of five children 
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(Figure 3). Few and moderate number of TGFβ-3 containing epitheliocytes we 
found each in one case. Connective tissue demonstrated very variable number 
of TGFβ-3 positive structures. Mainly we observed few or moderate number 
immunoreactive cells in the connective tissue and in the walls of blood ves-
sels. One tissue sample demonstrated richly stained vascular endothelial and 
smooth muscle cells (Figure 4).
 Figure 3. Expression of TGFβ-3 in basal 
epithelial cells. TGFβ-3 IMH, X 250.
Figure 4. Numerous TGFβ-3 positive 
vascular endothelial and smooth muscle 
cells. TGFβ-3 IMH, X 400.
Expression of MMP-8 was found in cleft lip and palate affected epithelium 
of eight patients. We observed few positive cells in three cases and moderate 
number – also in three cases. Mentioned epitheliocytes mainly were localized 
in the middle layers of stratified squamous epithelium and frequently were 
vacuolized (Figure 5). Tissue of one child demonstrated positive reaction of 
basal cells as well as cells of sebaceous gland. We didn’t find any MMP-8 posi-
tive structure in the underlying connective tissue.
MMP-9 positive epithelial cells were seen in the tissue of nine patients. 
Moderate to numerous number of immunoreactive cells was observed in two 
cases, moderate – in two cases, few – in four cases. Mainly positive reaction 
demonstrated cells in the middle layers of epithelium, but in three cases it 
was seen in basal cells. MMP-9 marked occasional epitheliocytes in the tissue 
material of one child. MMP-9 positive structures in connective tissue were 
found in the range from absence to numerous in the visual field. We observed 
numerous fibroblasts, macrophages and lymphocytes in the tissue material of 
one patient, moderate number of connective tissue cells as well as endothelio-
cytes and vascular smooth muscle cells – in four cases (Figure 6). Two cleft 
disordered connective tissue demonstrated few positive cells in subepithelium, 
but another two – occasional positive cells. 
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 Figure 5. Regionally located MMP-8 posi-
tive epithelial cells. MMP-8 IMH, X 200.
Figure 6. Expression of MMP-9 in connec-
tive tissue and vascular endothelial cells. 
MMP-9 IMH, X 400.
Expression of TIMP-2 was observed in the cleft lip and palate affected epithe-
lium of nine patients. Three tissue samples demonstrated occasional positive 
epithelial cells, two – few, but one – few to moderate. In all these cases immu-
noreactivity mainly was seen in the regionally localized and vacuolized cells 
of middle layers of stratified squamous epithelium. We observed moderate 
number of TIMP-2 containing epithelial cells in the tissue of two children and 
moderate to numerous – in one tissue sample. We detected also richly stained 
cells of sebaceous glands in the tissue of two patients. Expression of TIMP-2 in 
underlying connective tissue was less pronounced. We saw occasional positive 
cells of connective tissue in one case and numerous fibroblasts, macrophages 
and plasma cells also in one case. Four tissue samples demonstrated immu-
noreactive vascular smooth muscle cells, and relative amount of them varied 
between occasional to moderate.
DISCUSSION
Genetic expression is clearly predominant during embrional craniofacial mor-
phogenesis. It is estimated that above two third of human genes play a role 
in craniofacial development [4]. Moreover, there are data about 40 candidate 
genes association with cleft lip and palate patients from Baltic region – Esto-
nia, Latvia and Lithuania [18]. The genes are responsible for normal develop-
ment and encode many different products, including signaling molecules and 
its receptors, component of extracellular matrix and enzymes [4]. 
Several families of transcription factors are expressed in the ectomesen-
chyme, including PAX. PAX9 expression is restricted to prospective tooth 
mesenchyme at the bud stage, marking the sites of future tooth formation. 
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PAX9 also is expressed in the developing facial processes [2, 4]. It is empha-
sized that mentioned gene is necessary for the capability of the shelves to ele-
vate and to form normal shape [9]. Further, Hilliard with coworkers specify 
that the expression of PAX9 restricted to the posterior region during palate 
development and disruption of this gene in mice results in cleft palate [10, 13]. 
Our results showed that expression of PAX9 in tissue taken from cleft lip and 
palate region is more pronounced exactly in epithelium, but not in the tissue 
of ectomesenchymal origin. Since PAX9 is a key regulator in mesenchyme 
during the development and it increases mesenchymal cell proliferation [8], we 
suppose that thus epithelial tissue demonstrate compensatory ability and epi-
thelial cells facilitate underlying cells of mesenchymal origin, what ultimately 
will influence wound healing and regeneration.
In general, cleft lip and palate disordered tissue showed weak RYK expres-
sion. Halford with colleges report that RYK-deficient mice have a distinc-
tive craniofacial appearance, shortened limbs and postnatal mortality due 
to feeding and respiratory complications associated with a complete cleft of 
the secondary palate [7]. Data about about specific RYK expression during 
development of secondary palate practically are not found. Thereby our results 
demonstrate that RYK gene is inessential in postnatal pathogenesis.
 TGFβ-3 is key regulator in fusion of the palatal seam [14]. It influences 
synthesis of glycosaminoglycan – hyaluronan. Studies show that hyaluronan 
is synthesized by both the epithelium and mesenchyme. In normal palate 
development it has been proposed that the main intrinsic force for elevation is 
provided by hyaluronan [6]. Interestingly, TGFβ-3 affects expression of PAX9. 
Sasaki with coworkers report, that in TGF-β3 null mice expression of PAX9 
was reduced medially on unfused palates [23]. Our results also showed quite 
pronounced expression of TGFβ-3 in cleft lip and palate disordered tissue, 
especially in epithelium. Thereby we can suppose that mentioned growth fac-
tor probably is delayed, but still tissue remodeling contributing signal. More-
ower, recent studies confirm, that TGFβ-3 prevents scarring of buccal mucosa 
and vocal folds [19, 20]. 
Balance between MMPs and TIMPs is among the critical determinants that 
control the integrity of the ECM and subsequently affect cell fate. Blavier with 
colleges report that TIMP-2 is diffusely expressed in the mesenchymal tissue 
of the palate and very intensely apperas at the site of contact between the pala-
tal shelves [1]. It is immunohistochemically demonstrated that MMP-9 also is 
expressed during palate development [3]. Our results showed in general slight 
expression of MMP-8 in epithelium, more pronounced expression MMP-9 
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in epithelium and underlying connective tissue and very variable number of 
TIMP-2 positive structures. Interestingly, tissue analysis showed regularity: 
tissue samples with more relative number of TIMP-2 positive structures had 
also more MMP-9 positive structures. Moreover, expression of MMP-9 slightly 
predominated and was found also in the basal epithelial cells. It is known, that 
MMP-9 (gelatinase) digests a number of ECM molecules including type IV, 
V and XI collagens, laminin, aggrecan and core protein [16]. Thus we suggest 
that cleft lip and palate affected tissue demonstrate weak, but at the same time 
positive signal for tissue remodeling possibilities. 
Thus we conclude:
1. expression of PAX9 is more characteristic for cleft lip and palate affected 
tissue and probably facilitates tissue reconstruction due to its mitogenic 
effect,
2. rich expression of TGFβ-3 in cleft lip and palate disordered tissue may play 
a role in successful tissue remodelling and scar-free healing,
3. cleft lip and palate disordered tissue are characterizied by more pronounced 
expression of MMP-9, it slightly predominate expression of TIMP-2, giv-
ing evidence to the involvement of this mentioned factors in the postnatal 
tissue remodeling.
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